Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Seth Rotz

Showing results (21-30 of 35) with videos related to

Pageof 4
Sort By:
Transplantation and Cellular Therapy|April 26, 2026
Eculizumab for Pediatric Hematopoietic Cell Transplant Associated Thrombotic Microangiopathy: Real World Response Rates, Predictors of Poor Response, and an Optimal Timepoint for Treatment Response AssessmentMichelle L Schoettler, Geoffrey Cheng, Christine S Higham, et al.
Transplantation and Cellular Therapy|May 12, 2025
Multicenter Study on Caregiver Experiences in Pediatric Hematopoietic Stem Cell Transplantation: Part II. Treatment Challenges, Communication Barriers, and Caregiver-Driven Approaches to MitigationRachel Phelan, Seth Rotz, Christopher E Dandoy, et al.
Transplantation and Cellular Therapy|April 23, 2025
Multicenter Study on Caregiver Experiences in Pediatric Hematopoietic Stem Cell Transplantation Part I: Integrative Analysis of Mental Health, Psychosocial Stressors, and Support MechanismsNeel S Bhatt, Leslie Lehmann, Christopher E Dandoy, et al.
Blood Advances|December 21, 2023
Intensive care risk and long-term outcomes in pediatric allogeneic hematopoietic cell transplant recipientsMatt S Zinter, Ruta Brazauskas, Joelle Strom, et al.
Medrxiv : the Preprint Server for Health Sciences|August 14, 2023
Critical Illness Risk and Long-Term Outcomes Following Intensive Care in Pediatric Hematopoietic Cell Transplant RecipientsMatt S Zinter, Ruta Brazauskas, Joelle Strom, et al.
Transplantation and Cellular Therapy|February 13, 2022
Quality Improvement in Hematopoietic Stem Cell Transplant and Cellular Therapy: Using the Model for Improvement to impact OutcomesMalika Kapadia, Leslie Lehmann, Jeffery Auletta, et al.
Blood Advances|February 11, 2021
A pragmatic multi-institutional approach to understanding transplant-associated thrombotic microangiopathy after stem cell transplantChristopher E Dandoy, Seth Rotz, Priscila Badia Alonso, et al.
Transplantation and Cellular Therapy|January 1, 2025
Engraft: A Collaborative Learning Health Network for Enhanced Transplant and Cellular Therapy OutcomesChristopher E Dandoy, Jeffery J Auletta, Priscila Badia, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|November 28, 2018
Ocular Graft-versus-Host Disease after Hematopoietic Cell Transplantation: Expert Review from the Late Effects and Quality of Life Working Committee of the Center for International Blood and Marrow Transplant Research and Transplant Complications Working Party of the European Society of Blood and Marrow TransplantationYoshihiro Inamoto, Nuria Valdés-Sanz, Yoko Ogawa, et al.
Bone Marrow Transplantation|December 12, 2018
Ocular graft-versus-host disease after hematopoietic cell transplantation: Expert review from the Late Effects and Quality of Life Working Committee of the CIBMTR and Transplant Complications Working Party of the EBMTYoshihiro Inamoto, Nuria Valdés-Sanz, Yoko Ogawa, et al.
Pageof 4

Showing results (21-30 of 35) with videos related to

Sort By:
Pageof 4
Transplantation and Cellular Therapy|April 26, 2026
Eculizumab for Pediatric Hematopoietic Cell Transplant Associated Thrombotic Microangiopathy: Real World Response Rates, Predictors of Poor Response, and an Optimal Timepoint for Treatment Response AssessmentMichelle L Schoettler, Geoffrey Cheng, Christine S Higham, et al.
Transplantation and Cellular Therapy|May 12, 2025
Multicenter Study on Caregiver Experiences in Pediatric Hematopoietic Stem Cell Transplantation: Part II. Treatment Challenges, Communication Barriers, and Caregiver-Driven Approaches to MitigationRachel Phelan, Seth Rotz, Christopher E Dandoy, et al.
Transplantation and Cellular Therapy|April 23, 2025
Multicenter Study on Caregiver Experiences in Pediatric Hematopoietic Stem Cell Transplantation Part I: Integrative Analysis of Mental Health, Psychosocial Stressors, and Support MechanismsNeel S Bhatt, Leslie Lehmann, Christopher E Dandoy, et al.
Blood Advances|December 21, 2023
Intensive care risk and long-term outcomes in pediatric allogeneic hematopoietic cell transplant recipientsMatt S Zinter, Ruta Brazauskas, Joelle Strom, et al.
Medrxiv : the Preprint Server for Health Sciences|August 14, 2023
Critical Illness Risk and Long-Term Outcomes Following Intensive Care in Pediatric Hematopoietic Cell Transplant RecipientsMatt S Zinter, Ruta Brazauskas, Joelle Strom, et al.
Transplantation and Cellular Therapy|February 13, 2022
Quality Improvement in Hematopoietic Stem Cell Transplant and Cellular Therapy: Using the Model for Improvement to impact OutcomesMalika Kapadia, Leslie Lehmann, Jeffery Auletta, et al.
Blood Advances|February 11, 2021
A pragmatic multi-institutional approach to understanding transplant-associated thrombotic microangiopathy after stem cell transplantChristopher E Dandoy, Seth Rotz, Priscila Badia Alonso, et al.
Transplantation and Cellular Therapy|January 1, 2025
Engraft: A Collaborative Learning Health Network for Enhanced Transplant and Cellular Therapy OutcomesChristopher E Dandoy, Jeffery J Auletta, Priscila Badia, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|November 28, 2018
Ocular Graft-versus-Host Disease after Hematopoietic Cell Transplantation: Expert Review from the Late Effects and Quality of Life Working Committee of the Center for International Blood and Marrow Transplant Research and Transplant Complications Working Party of the European Society of Blood and Marrow TransplantationYoshihiro Inamoto, Nuria Valdés-Sanz, Yoko Ogawa, et al.
Bone Marrow Transplantation|December 12, 2018
Ocular graft-versus-host disease after hematopoietic cell transplantation: Expert review from the Late Effects and Quality of Life Working Committee of the CIBMTR and Transplant Complications Working Party of the EBMTYoshihiro Inamoto, Nuria Valdés-Sanz, Yoko Ogawa, et al.
Pageof 4